Sanofi Genzyme retreats from its Parkinson’s bargain by gene medication upstart Voyager, portion of an $845M pact
Health and beauty
6:07:00 AM
Voyager $VYGR plans to launch a pivotal research of its leading gene medication for Parkinson's illness before the finish of the year, h...